AZ struck out in May in trying to expand Fasenra into COPD. But it does have new long-term data that could bolster the drug in its current indication.
NICE said yes to Novartis’ Tafinlar and Mekinist in adjuvant melanoma, giving the company a head start over rival BMS.
After months of pretrial proceedings and four weeks at trial, Imerys chose to settle a mesothelioma case in California.
The policy revelation shows just how eager Novartis is in addressing some latest ethics shortfalls.
Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.
Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its…
Drug manufacturers were shaking off the remnants of Hurricane Florence on Monday after the dangers from the storm morphed into hazardous flooding.
AstraZeneca’s latest data on its triple-combination COPD candidate may not do much to help it against rival GlaxoSmithKline.
Astellas is reupping its sponsorship of ABC’s “Dancing With the Stars,” partnering with former pro boxer and TV personality Laila Ali.
The new eczema data came a month ahead of an expected FDA decision on the drug's fate in asthma.
